01.10.2011 | Original Research
Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study
Erschienen in: Advances in Therapy | Ausgabe 10/2011
Einloggen, um Zugang zu erhalten